Clinical and pathological features of post-transplant lymphoproliferative disorders (PTLD).

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

16 citing papers in PubMed.

1. Double-step PCR assay to quantify Epstein-Barr viral load in peripheral blood.Molecular biotechnology · 2004
   Trial
2. Research landmarks on the 60th anniversary of Epstein-Barr virus.Science China. Life sciences · 2025
   Review
3. Epstein-Barr virus infection: the micro and macro worlds.Virology journal · 2023
   Review
4. Validation of a Post-Transplant Lymphoproliferative Disorder Risk Prediction Score and Derivation of a New Prediction Score Using a National Bone Marrow Transplant Registry Database.The oncologist · 2021
   Article
5. Risk of diffuse large B-cell lymphoma after solid organ transplantation in the United States.American journal of hematology · 2014
   Article
6. EBV-specific CD8+ T cells from asymptomatic pediatric thoracic transplant patients carrying chronic high EBV loads display contrasting features: activated phenotype and exhausted function.Journal of immunology (Baltimore, Md. : 1950) · 2011
   Article
7. CD4 and CD8 T cell responses to tumour-associated Epstein-Barr virus antigens in nasopharyngeal carcinoma patients.Cancer immunology, immunotherapy : CII · 2008
   Article
8. Regression of Epstein-Barr virus-induced B-cell transformation in vitro involves virus-specific CD8+ T cells as the principal effectors and a novel CD4+ T-cell reactivity.Journal of virology · 2005
   Article
9. Dual stimulation of Epstein-Barr Virus (EBV)-specific CD4+- and CD8+-T-cell responses by a chimeric antigen construct: potential therapeutic vaccine for EBV-positive nasopharyngeal carcinoma.Journal of virology · 2004
   Article
10. Latent gene sequencing reveals familial relationships among Chinese Epstein-Barr virus strains and evidence for positive selection of A11 epitope changes.Journal of virology · 2003
    Article
11. Phosphatidylinositol 3-kinase is essential for the proliferation of lymphoblastoid cells.Oncogene · 2002
    Article
12. Epstein-Barr virus infection in paediatric liver transplant recipients: detection of the virus in post-transplant tonsillectomy specimens.Molecular pathology : MP · 2001
    Article
13. Quantitative monitoring of circulating Epstein-Barr virus DNA for predicting the development of posttransplantation lymphoproliferative disease.International journal of hematology · 2001
    Article
14. Pediatric solid-organ transplant recipients carry chronic loads of Epstein-Barr virus exclusively in the immunoglobulin D-negative B-cell compartment.Journal of clinical microbiology · 2001
    Article
15. The role of EBV in post-transplant malignancies: a review.Journal of clinical pathology · 2000
    Review
16. Recent advancements in hematopoietic stem cell transplantation in Taiwan.Tzu chi medical journal
    Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as